Mannheim, Germany

Jaques Blummel


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jaques Blummel: Innovator in Therapeutic and Diagnostic Applications

Introduction

Jaques Blummel is a notable inventor based in Mannheim, Germany. He has made significant contributions to the field of therapeutic and diagnostic applications through his innovative work. His expertise in polymeric particles has led to advancements that enhance medical procedures.

Latest Patents

Jaques Blummel holds a patent for "Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same." This patent describes polymeric particles designed for use in therapeutic and diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene and/or a derivative thereof, which may be present throughout the particles or within an outer coating. Additionally, the particles may feature a core made from a hydrogel formed from an acrylic-based polymer. These particles can be provided in specific sizes to facilitate selective embolization of certain sized blood vessels or localized treatment with an active component agent. Furthermore, the invention includes color-coded microspheres or nanospheres to allow for easy identification during use.

Career Highlights

Jaques Blummel is currently associated with Varian Medical Systems, Inc., where he continues to develop innovative solutions in the medical field. His work has been instrumental in advancing the capabilities of therapeutic and diagnostic applications.

Collaborations

Jaques has collaborated with notable colleagues, including Ulf Fritz and Olaf Fritz, to further enhance the impact of his inventions in the medical community.

Conclusion

Jaques Blummel's contributions to the field of therapeutic and diagnostic applications through his innovative patents demonstrate his commitment to improving medical procedures. His work with polymeric particles is paving the way for advancements in targeted treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…